References
McLaughlin CC, Wu XC, Jemal A, et al. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000–7.
Chi Z, Li S, Sheng X, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85.
Lian B, Cui CL, Zhou L, et al. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively followed patients. Ann Oncol. 2017;28(4):868–73.
Heppt MV, Roesch A, Weide B, et al. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer. 2017;81:36–44.
Chuan LC, Bin L, Li Z, et al. Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients. Annal Surg Oncol. 2018;25(8):2184–92.
Cui C, Lian B, Zhang X, et al. An evidence-based staging system for mucosal melanoma: a proposal. Ann Surg Oncol. 2022;29(8):5221–34.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Guo, J., Balch, C.M. Letter to the Editor Concerning “An Evidence-Based Staging System for Mucosal Melanoma: A Proposal,” by Smith, Henry et al.. Ann Surg Oncol 29 (Suppl 3), 626–627 (2022). https://doi.org/10.1245/s10434-022-12635-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12635-5